Nowa Pharmaceutical

Nowa Pharmaceutical is a clinical-stage biopharmaceutical company focused on the development of innovative long-acting injectable (LAI) formulations for the treatment of central nervous system (CNS) disorders and chronic pain. The company utilizes proprietary drug delivery platforms to improve patient compliance and therapeutic outcomes by extending the release profile of established and novel therapeutics. Its lead programs target high-unmet-need areas such as Parkinson's disease and opioid addiction. Nowa Pharmaceutical aims to bridge the gap between drug discovery and clinical application through advanced formulation science.